Last reviewed · How we verify
PCSK9 Antibody, PCSK9 Enzyme — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
PCSK9 Antibody, PCSK9 Enzyme (PCSK9 Antibody, PCSK9 Enzyme) — LifeBridge Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PCSK9 Antibody, PCSK9 Enzyme TARGET | PCSK9 Antibody, PCSK9 Enzyme | LifeBridge Health | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PCSK9 Antibody, PCSK9 Enzyme CI watch — RSS
- PCSK9 Antibody, PCSK9 Enzyme CI watch — Atom
- PCSK9 Antibody, PCSK9 Enzyme CI watch — JSON
- PCSK9 Antibody, PCSK9 Enzyme alone — RSS
Cite this brief
Drug Landscape (2026). PCSK9 Antibody, PCSK9 Enzyme — Competitive Intelligence Brief. https://druglandscape.com/ci/pcsk9-antibody-pcsk9-enzyme. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab